Literature DB >> 12016015

Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma.

Hairui Liang1, Michael B Kays, Kevin M Sowinski.   

Abstract

A selective, sensitive and accurate liquid chromatographic method with UV and fluorescence detection was developed, validated and applied for the determination of fluoroquinolones in human plasma. The effects of mobile phase composition, ion-pair and competing-base reagents, buffers, pH, and acetonitrile concentrations were investigated on the separation of six quinolones (cinoxacin, levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin and trovafloxacin). Sample preparation was carried out by adding internal standard and displacing agent and processing by ultrafiltration. This method uses ultraviolet and fluorescence detection and separation using a C(18) column. The recovery, selectivity, linearity, precision, and accuracy of the method were evaluated from spiked human plasma samples. The method was successfully applied to patient plasma samples in support of a levofloxacin pharmacokinetic study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016015     DOI: 10.1016/s1570-0232(02)00046-6

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  14 in total

1.  Penetration of levofloxacin into the anterior chamber (aqueous humour) of the human eye after intravenous administration.

Authors:  E García-Vázquez; J Mensa; M Sarasa; Y López; P D Couchard; D Soy; J R Fontenla
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

2.  Levofloxacin pharmacokinetics in adult cystic fibrosis.

Authors:  Carlton K K Lee; Michael P Boyle; Marie Diener-West; Lois Brass-Ernst; Michelle Noschese; Pamela L Zeitlin
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

3.  Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.

Authors:  Kalliopi Chatzika; Katerina Manika; Paschalina Kontou; Georgia Pitsiou; Despina Papakosta; Konstantinos Zarogoulidis; Ioannis Kioumis
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

4.  Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.

Authors:  Ioannis Skiadas; Angelos Pefanis; Apostolos Papalois; Aspasia Kyroudi; Helen Triantafyllidi; Thomas Tsaganos; Helen Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

5.  Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.

Authors:  Johnny W Peterson; Scott T Moen; Daniel Healy; Jennifer E Pawlik; Joanna Taormina; Jason Hardcastle; John M Thomas; William S Lawrence; Cindy Ponce; Bagram M Chatuev; Bryan T Gnade; Sheri M Foltz; Stacy L Agar; Jian Sha; Gary R Klimpel; Michelle L Kirtley; Tonyia Eaves-Pyles; Ashok K Chopra
Journal:  Open Microbiol J       Date:  2010-06-03

6.  Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients.

Authors:  V Talla; Pr Veerareddy
Journal:  J Young Pharm       Date:  2011-10

7.  Improved HPLC method for the determination of moxifloxacin in application to a pharmacokinetics study in patients with infectious diseases.

Authors:  Nan Wang; Liqin Zhu; Xuequn Zhao; Wenjie Yang; He Sun
Journal:  ISRN Pharmacol       Date:  2013-05-26

8.  High-performance liquid chromatography assay for moxifloxacin in brain tissue and plasma: validation in a pharmacokinetic study in a murine model of cerebral listeriosis.

Authors:  Renaud Respaud; Solene Grayo; Eric Singlas; Sophie Dubouch; Alban Le Monnier; Marie-Catherine Lott
Journal:  J Anal Methods Chem       Date:  2012-03-14       Impact factor: 2.193

9.  validated microbiological and HPLC methods for the determination of moxifloxacin in pharmaceutical preparations and human plasma.

Authors:  Ahmed A Abdelaziz; Tarek E Elbanna; Noha M Gamaleldeen
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  A Peroxidase-linked Spectrophotometric Assay for the Detection of Monoamine Oxidase Inhibitors.

Authors:  Kangkang Zhi; Zhongduo Yang; Jie Sheng; Zongmei Shu; Yin Shi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.